ELOX — Eloxx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Eloxx Announces Publication Of Scientific Manuscript On ELX-02 In The Journal Of Clinical Pharmacology
Brief: Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation To Provide Increased Funding And Support For Elx-02 Global Phase 2 Clinical Trial Program
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:14 PM
Brief: Eloxx Pharmaceuticals Reports Third Quarter 2020 Financial And Operating Results And Provides Business Update
Brief: Eloxx Announces The Publication Of Two Manuscripts On ELX-02 And It’S ERSG Library In Two Leading Journals
Brief: Eloxx Pharma Resumes Enrollment In U.S. Phase 2 Clinical Trial In Cystic Fibrosis
Brief: Eloxx Pharmaceuticals Reports Q2 Loss Per Share Of $0.20
Brief: Eloxx Pharmaceuticals Receives U.S. Orphan Drug Designation For Elx-02 For The Treatment Of Cystic Fibrosis
Brief: Eloxx Pharmaceuticals Says Enrollment In Phase 2 Clinical Trial In Cystic Fibrosis Has Resumed In Israel And Europe
U.S. RESEARCH ROUNDUP-Grubhub, Starbucks, Trivago
U.S. RESEARCH ROUNDUP-Digital Realty Trust, Pilgrims Pride, Terraform Power
Brief: Eloxx Pharmaceuticals Provides Update On The Impact Of Novel Coronavirus On Phase 2 Clinical Trials In Cystic Fibrosis
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 08:30 AM
U.S. RESEARCH ROUNDUP-Apache, Costco Wholesale, Teladoc Health
Brief: Eloxx Pharmaceuticals Reports Q4 Loss Per Share $0.29
Brief: Eloxx Pharmaceuticals Says Board Approved Leadership And Organizational Re-Alignment
Brief: Eloxx Strengthens Its Commitment To Cystic Fibrosis Through Reallocating Resources
U.S. RESEARCH ROUNDUP- Corteva, Essent Group, Ventas
Brief: Eloxx Pharmaceuticals Provides Update On Progress Of Phase 2 Clinical Programs For Elx-02 And ERSG Pipeline